Next in line

WuXi NextCODE's $75 million series B could fuel path to IPO

WuXi NextCODE Genomics Inc. could be the final New WuXi Life Science Ltd. subsidiary to head for an IPO.

NextCODE, one of three New WuXi subsidiaries, announced May 1 that it raised $75 million in

Read the full 341 word article

User Sign In